Trial record 1 of 35 for:
Aurora Nash
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03028740 |
|
Recruitment Status :
Terminated
(This study was terminated early due to lack of efficacy based on the results of Part I of the AURORA study.)
First Posted : January 23, 2017
Last Update Posted : April 5, 2021
|
Sponsor:
Tobira Therapeutics, Inc.
Information provided by (Responsible Party):
Tobira Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 12, 2021 |
| Actual Study Completion Date : | March 9, 2021 |